| Literature DB >> 23577248 |
Siripong Sirikurnpiboon1, Paiboon Jivapaisarnpong.
Abstract
Introduction. Single-access laparoscopic surgery (SALS) has been successfully introduced for colectomy surgery; however, for mid to low rectum procedures such as total mesorectal excision, it can be technically complicated. In this study, we introduced a single-access technique for rectum cancer operations without the use of other instruments. Aims. To show the short-term results of single-access laparoscopic rectal surgery in terms of pathologic results and immediate complications. Settings and Design. Prospective study. Materials and Methods. We selected middle rectum to anal canal cancer patients to undergo single-access laparoscopic rectal resection for rectal cancer. All patients had total mesorectal excisions. An umbilical incision was made for the insertion of a single multichannel port, and a mesocolic window was created to identify the inferior mesenteric artery and vein. Total mesorectal excision was performed. There were no perioperative complications. The mean operative time was 269 minutes; the median hospital stay was 7 days; the mean wound size was 5.5 cm; the median number of harvested lymph nodes was 15; and all patients had intact mesorectal capsules. Statistical Analysis Used. Mean, minimum-maximum. Conclusion. Single-access laparoscopic surgery for rectal cancer is feasible while oncologic principles and patient safety are maintained.Entities:
Year: 2013 PMID: 23577248 PMCID: PMC3615606 DOI: 10.1155/2013/687134
Source DB: PubMed Journal: Minim Invasive Surg ISSN: 2090-1445
Figure 1Port position.
Figure 2Splenic flexure mobilization.
Figure 3Pelvic dissection.
Figure 4Position of placed Endo articulating linear stapler.
Demographic data.
| Age (mean, years) | 69 ± 11.76 (52–86) |
| BMI (mean, min–max) | 21.77 ± 4.48 (15.00–30.00) |
| Sex (male/female) | 6/4 |
| ASA classification (median, min–max) | 2 (1–3) |
| Location of tumor | |
| Anal canal/lower rectum | 9 |
| Middle rectum | 1 |
| Clinical stage | |
| Stage II | 2 |
| Stage III | 8 |
Operation and pathologic result.
| Operation | |
| APR | 9 |
| LAR | 1 |
| Surgical time (minutes) | 269 ± 41.75 (200–300) |
| Blood loss (mL) | 145 ± 76.19 (50–300) |
| Pathologic result | |
| T stage | T3—7 patients |
| Lymph node retrieval | 15 (8–30) |
| Quirk mesorectal grading [ | Grade 3—9 patients |
| CRM | All negative |
| Pathologic staging | |
| Stage II | 4 |
| Stage III | 6 |
Postoperative details and complications.
| Immediate postoperative complication | |
| Postoperative lung atelectasis | 2 |
| Perineal wound infection | 1 |
| Thrombophlebitis | 1 |
| Postoperative delirium | 2 |
| Hospital stay (day) (median, min–max) | 7 (5–10) |
| 30-day mortality | 0 |
| Postoperative first bowel movement (day) (median, min–max) | 3 (2-3) |
| Port site wound length (cm) (mean, range) | 5.5 ± 0.44 (5-6) |
Figure 5Specimen in LAR.
Figure 6Postoperative wound length.
Previous results in Single access rectal cancer surgery.
| Author, year | Patient number | Operation | Special Technique or Instrument | Port type | Mean operative time (minutes) | Staging | Mean wound length | Quirke's mesorectal fascia grade |
|---|---|---|---|---|---|---|---|---|
|
Hamzaoglu et al., 2011 [ | 4 | 3 LAR | Suture-hung sigmoid with abdominal wall | Triport | 347 | 2 stage III 2 stage I | 3.5 cm | 3 |
| Uematsu et al., 2011 [ | 7 | LAR | Suspending bar and extracorporeal magnet | Self innovation | 205 | 2, stage II 5 stage III | 3 cm | NA |
| Hirano et al., 2012 [ | 15 | AR | NA | EZ lap protector + 12 mm port | 276 | 0 stage 0 | 2.8 cm | NA |
| Hua-Feng et al., 2012 [ | 20 | APR | Start from perineal resection phase | Self-innovation | 138 | NA | NA | NA |
LAR: low anterior resection, TAE: transabdominal anal excision, AR: anterior resection, APR: abdominoperineal resection.